Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): : An international, double-blind, randomised placebo-controlled trial
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 38794150
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(13)62292-8
- Title of journal
- The Lancet
- Article number
- -
- First page
- 1041
- Volume
- 383
- Issue
- 9922
- ISSN
- 0140-6736
- Open access status
- Out of scope for open access requirements
- Month of publication
- March
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
12
- Research group(s)
-
A - Cancer Sciences
- Citation count
- 316
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
